img

Global Small Molecule Anti-tumor Targted Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Small Molecule Anti-tumor Targted Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Small Molecule Anti-tumor Targted Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Small Molecule Anti-tumor Targted Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Liver Cancer and Colorectal Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Small Molecule Anti-tumor Targted Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Small Molecule Anti-tumor Targted Drug key companies include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. Astrazeneca, Novartis, Millennium Pharmaceuticals are top 3 players and held % share in total in 2022.
Small Molecule Anti-tumor Targted Drug can be divided into EGFR, ALK, Bcr-Abl and Others, etc. EGFR is the mainstream product in the market, accounting for % share globally in 2022.
Small Molecule Anti-tumor Targted Drug is widely used in various fields, such as Liver Cancer, Colorectal Cancer, Lung Cancer and Gastric Cancer, etc. Liver Cancer provides greatest supports to the Small Molecule Anti-tumor Targted Drug industry development. In 2022, global % share of Small Molecule Anti-tumor Targted Drug went into Liver Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Small Molecule Anti-tumor Targted Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Segment by Type
EGFR
ALK
Bcr-Abl
Others

Segment by Application


Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Small Molecule Anti-tumor Targted Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Small Molecule Anti-tumor Targted Drug introduction, etc. Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Small Molecule Anti-tumor Targted Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Small Molecule Anti-tumor Targted Drug
1.1 Small Molecule Anti-tumor Targted Drug Market Overview
1.1.1 Small Molecule Anti-tumor Targted Drug Product Scope
1.1.2 Small Molecule Anti-tumor Targted Drug Market Status and Outlook
1.2 Global Small Molecule Anti-tumor Targted Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Small Molecule Anti-tumor Targted Drug Market Size by Region (2024-2034)
1.4 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Region (2024-2024)
1.5 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
1.6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
1.6.2 Europe Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
1.6.4 Latin America Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size (2024-2034)
2 Small Molecule Anti-tumor Targted Drug Market by Type
2.1 Introduction
2.1.1 EGFR
2.1.2 ALK
2.1.3 Bcr-Abl
2.1.4 Others
2.2 Global Small Molecule Anti-tumor Targted Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Type (2024-2034)
3 Small Molecule Anti-tumor Targted Drug Market Overview by Application
3.1 Introduction
3.1.1 Liver Cancer
3.1.2 Colorectal Cancer
3.1.3 Lung Cancer
3.1.4 Gastric Cancer
3.1.5 Breast Cancer
3.1.6 Esophageal Cancer
3.1.7 Others
3.2 Global Small Molecule Anti-tumor Targted Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue Breakdown by Application (2024-2034)
4 Small Molecule Anti-tumor Targted Drug Competition Analysis by Players
4.1 Global Small Molecule Anti-tumor Targted Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2022)
4.3 Date of Key Players Enter into Small Molecule Anti-tumor Targted Drug Market
4.4 Global Top Players Small Molecule Anti-tumor Targted Drug Headquarters and Area Served
4.5 Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Anti-tumor Targted Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Astrazeneca
5.1.1 Astrazeneca Profile
5.1.2 Astrazeneca Main Business
5.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.1.4 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Astrazeneca Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.2.4 Novartis Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Novartis Recent Developments
5.3 Millennium Pharmaceuticals
5.3.1 Millennium Pharmaceuticals Profile
5.3.2 Millennium Pharmaceuticals Main Business
5.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.3.4 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.4.4 Bayer Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Bayer Recent Developments
5.5 Exelixis
5.5.1 Exelixis Profile
5.5.2 Exelixis Main Business
5.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.5.4 Exelixis Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Exelixis Recent Developments
5.6 Abbvie
5.6.1 Abbvie Profile
5.6.2 Abbvie Main Business
5.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.6.4 Abbvie Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Abbvie Recent Developments
5.7 Boehringer-Ingelheim
5.7.1 Boehringer-Ingelheim Profile
5.7.2 Boehringer-Ingelheim Main Business
5.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.7.4 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Boehringer-Ingelheim Recent Developments
5.8 Eisai
5.8.1 Eisai Profile
5.8.2 Eisai Main Business
5.8.3 Eisai Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.8.4 Eisai Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Eisai Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.9.4 Pfizer Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Pfizer Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Profile
5.10.2 Bristol-Myers Squibb Main Business
5.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.10.4 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Bristol-Myers Squibb Recent Developments
5.11 Roche
5.11.1 Roche Profile
5.11.2 Roche Main Business
5.11.3 Roche Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.11.4 Roche Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.11.5 Roche Recent Developments
5.12 Bettapharma
5.12.1 Bettapharma Profile
5.12.2 Bettapharma Main Business
5.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
5.12.4 Bettapharma Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Bettapharma Recent Developments
6 North America
6.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Anti-tumor Targted Drug Market Dynamics
11.1 Small Molecule Anti-tumor Targted Drug Industry Trends
11.2 Small Molecule Anti-tumor Targted Drug Market Drivers
11.3 Small Molecule Anti-tumor Targted Drug Market Challenges
11.4 Small Molecule Anti-tumor Targted Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Small Molecule Anti-tumor Targted Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Small Molecule Anti-tumor Targted Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Region (2024-2024)
Table 4. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Small Molecule Anti-tumor Targted Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2022)
Table 39. Date of Key Players Enter into Small Molecule Anti-tumor Targted Drug Market
Table 40. Global Small Molecule Anti-tumor Targted Drug Key Players Headquarters and Area Served
Table 41. Small Molecule Anti-tumor Targted Drug Product Solution and Service
Table 42. Global Small Molecule Anti-tumor Targted Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Astrazeneca Basic Information List
Table 45. Astrazeneca Description and Business Overview
Table 46. Astrazeneca Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Astrazeneca (2024-2024)
Table 48. Astrazeneca Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Novartis (2024-2024)
Table 53. Novartis Recent Developments
Table 54. Millennium Pharmaceuticals Basic Information List
Table 55. Millennium Pharmaceuticals Description and Business Overview
Table 56. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Millennium Pharmaceuticals (2024-2024)
Table 58. Millennium Pharmaceuticals Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Bayer (2024-2024)
Table 63. Bayer Recent Developments
Table 64. Exelixis Basic Information List
Table 65. Exelixis Description and Business Overview
Table 66. Exelixis Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Exelixis (2024-2024)
Table 68. Exelixis Recent Developments
Table 69. Abbvie Basic Information List
Table 70. Abbvie Description and Business Overview
Table 71. Abbvie Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Abbvie (2024-2024)
Table 73. Abbvie Recent Developments
Table 74. Boehringer-Ingelheim Basic Information List
Table 75. Boehringer-Ingelheim Description and Business Overview
Table 76. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Boehringer-Ingelheim (2024-2024)
Table 78. Boehringer-Ingelheim Recent Developments
Table 79. Eisai Basic Information List
Table 80. Eisai Description and Business Overview
Table 81. Eisai Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Eisai (2024-2024)
Table 83. Eisai Recent Developments
Table 84. Pfizer Basic Information List
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Pfizer (2024-2024)
Table 88. Pfizer Recent Developments
Table 89. Bristol-Myers Squibb Basic Information List
Table 90. Bristol-Myers Squibb Description and Business Overview
Table 91. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Bristol-Myers Squibb (2024-2024)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Roche Basic Information List
Table 95. Roche Description and Business Overview
Table 96. Roche Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Roche (2024-2024)
Table 98. Roche Recent Developments
Table 99. Bettapharma Basic Information List
Table 100. Bettapharma Description and Business Overview
Table 101. Bettapharma Small Molecule Anti-tumor Targted Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Small Molecule Anti-tumor Targted Drug Business of Bettapharma (2024-2024)
Table 103. Bettapharma Recent Developments
Table 104. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2024) & (US$ Million)
Table 105. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034) & (US$ Million)
Table 106. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2024) & (US$ Million)
Table 107. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034) & (US$ Million)
Table 108. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 109. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2024-2024) & (US$ Million)
Table 110. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2024-2034) & (US$ Million)
Table 111. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Region (2024-2024)
Table 112. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Region (2024-2034)
Table 113. Latin America Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2024) & (US$ Million)
Table 115. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034) & (US$ Million)
Table 116. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 117. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2024) & (US$ Million)
Table 118. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2024-2034) & (US$ Million)
Table 119. Small Molecule Anti-tumor Targted Drug Market Trends
Table 120. Small Molecule Anti-tumor Targted Drug Market Drivers
Table 121. Small Molecule Anti-tumor Targted Drug Market Challenges
Table 122. Small Molecule Anti-tumor Targted Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Anti-tumor Targted Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Small Molecule Anti-tumor Targted Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of EGFR
Figure 11. Global EGFR Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of ALK
Figure 13. Global ALK Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Bcr-Abl
Figure 15. Global Bcr-Abl Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Type: 2022 & 2034
Figure 19. North America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Figure 20. Europe Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2024-2034)
Figure 24. Liver Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Lung Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Gastric Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Breast Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Esophageal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 30. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 31. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Application: 2022 & 2034
Figure 32. North America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Figure 33. Europe Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Figure 34. Asia-Pacific Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Figure 35. Latin America Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Figure 36. Middle East and Africa Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2024-2034)
Figure 37. Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 38. Global Top 5 and Top 10 Players Small Molecule Anti-tumor Targted Drug Market Share in 2022
Figure 39. North America Small Molecule Anti-tumor Targted Drug Market Share by Country (2024-2034)
Figure 40. U.S. Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Canada Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Germany Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 43. France Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 44. U.K. Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 45. Italy Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Russia Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Nordic Countries Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Region (2024-2034)
Figure 49. China Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Japan Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 51. South Korea Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 53. India Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Australia Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Latin America Small Molecule Anti-tumor Targted Drug Market Share by Country (2024-2034)
Figure 56. Mexico Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 57. Brazil Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 58. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Country (2024-2034)
Figure 59. Turkey Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 60. Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 61. UAE Small Molecule Anti-tumor Targted Drug Market Size (2024-2034) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report